The voice of people with chronic obstructive pulmonary disease (COPD) becomes more pitched and sounds breathy or hoarse at the early stages of disease exacerbations, which are episodes when symptoms suddenly worsen, according to a pilot study where 28 patients were asked to record their voices every day for…
One in six adults in the U.S. with chronic obstructive pulmonary disease (COPD) didn’t adhere to their medications due to costs, which is associated with a poor prognosis. That’s according to a study that analyzed data from a U.S. survey of adults with COPD between 2013-2020. Patients younger than…
Permanent night shift work is associated with a nearly 50% higher risk of developing chronic obstructive pulmonary disease (COPD) relative to day work, according to a large study of U.K. data. The risk of COPD was even higher among permanent night shift workers with high genetic susceptibility to the…
A Phase 3 clinical trial assessing the potential of triple-combination Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) to improve cardiopulmonary outcomes in people with chronic obstructive pulmonary disease (COPD) is opening at sites worldwide, AstraZeneca, which markets the inhaled therapy, announced. The THARROS study (NCT06283966) is expected to enroll up…
Remote monitoring reduced hospitalization rates and emergency room visits for patients with chronic obstructive pulmonary disease (COPD), a recent study has shown. At the same time, outpatient office visits increased, suggesting remote patient monitoring may help shift care to a less expensive and burdensome setting. “These results support the…
Biofourmis and Beacon Health System have partnered for an in-home monitoring program specifically meant for patients with complex chronic diseases, including chronic obstructive pulmonary disease (COPD), during their post-discharge period. Patient-reported data will be automatically collected, analyzed, and presented in a continuously updated dashboard visible to clinicians.
Signify Health, a U.S. healthcare platform, has added spirometry testing for chronic obstructive lung disease (COPD) to its in-home diagnostic and preventive services. The company began offering spirometry testing in select locations earlier this year, with at-home evaluations available to Medicare Advantage and Medicaid plan members. “In-home…
AeroRx Therapeutics is teaming up with HCmed Innovations to develop a new therapeutic combination of different classes of bronchodilators — medications that help open up the airways, making breathing easier — for the treatment of people with chronic obstructive pulmonary disease (COPD). The new combo would be delivered using…
Get regular updates to your inbox.